and have a tumor recurrence in or near prior radiation fields
Showing 26 - 50 of >10,000
Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
Recruiting
- Breast Cancer
- Whole breast irradiation +/- tumor bed boost
-
Seoul, Korea, Republic ofSamsung Medical Center
May 30, 2023
Sarcoma Trial in Chapel Hill (GRID therapy)
Not yet recruiting
- Sarcoma
- GRID therapy
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill, Department of Radia
Oct 5, 2023
Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)
Active, not recruiting
- Nonsmall Cell Lung Cancer
- NSCLC
- NovoTTF-200T
- Immune checkpoint inhibitors or docetaxel
-
Birmingham, Alabama
- +123 more
Oct 13, 2022
Pancreas Adenocarcinoma Trial in Leiden (Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101)
Not yet recruiting
- Pancreas Adenocarcinoma
- Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101
-
Leiden, NetherlandsLeiden University Medical Center
Aug 2, 2023
Breast Cancer Trial in Boston (Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort, Diffuse Optical
Enrolling by invitation
- Breast Cancer
- Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort
- Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort
-
Boston, MassachusettsBoston Medical Center
Sep 20, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +6 more
- Ipilimumab
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 12, 2022
Benign Tumor, Malignant Tumor Trial in Boston (Indocyanine green, SPY-PHI)
Recruiting
- Benign Neoplasm
- Malignant Neoplasm
- Indocyanine green
- SPY-PHI
-
Boston, MassachusettsMassachusetts General Hospital
Jan 20, 2023
Head and Neck Squamous Cell Carcinoma, Brain Metastases Trial in Nashville (Magnetic Resonance Imaging (MRI), Positron Emission
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Brain Metastases
- Magnetic Resonance Imaging (MRI)
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 10, 2023
Lung Cancer Trial in Caen, Marseille, Rouen (NOVATECH® LUCIOLA™ EB - (Fiducial Marker))
Recruiting
- Lung Cancer
- NOVATECH® LUCIOLA™ EB - (Fiducial Marker)
-
Caen, France
- +4 more
Jan 26, 2023
CNS Cancer, Head Neck Cancer, GI Cancer Trial in New York (Pencil Beam Scanning Proton Therapy)
Recruiting
- CNS Cancer
- +6 more
- Pencil Beam Scanning Proton Therapy
-
New York, New YorkThe New York Proton Center
Mar 29, 2022
Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)
Recruiting
- Breast Cancer
- +2 more
- Stereotactic Ablative Radiation Therapy
- +2 more
-
Cairo, EgyptNational Cancer Institute
Nov 20, 2023
Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in New Brunswick (Atezolizumab 1200 MG in 20 ML
Active, not recruiting
- Refractory Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Atezolizumab 1200 MG in 20 ML Injection
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Sep 27, 2022
Glioblastoma Trial in Rochester (radiation, procedure, drug, other)
Recruiting
- Glioblastoma
- Accelerated Hypofractionated Radiation Therapy
- +8 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 24, 2023
Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)
Not yet recruiting
- Non Small Cell Lung Cancer
- carboplatin chemotherapy
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 3, 2023
Triple Negative Breast Cancer Trial in New York (Merck 3475 Pembrolizumab, Intraoperative radiation therapy (IORT))
Recruiting
- Triple Negative Breast Cancer
- Merck 3475 Pembrolizumab
- Intraoperative radiation therapy (IORT)
-
New York, New YorkColumbia University Irving Medical Center
Oct 10, 2022
Breast Ductal Carcinoma In Situ Trial in Worldwide (other, biological, radiation)
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- Laboratory Biomarker Analysis
- +2 more
-
Anniston, Alabama
- +1267 more
Jan 28, 2023
Low-grade Glioma Trial in San Francisco (ReMind iPad app, Healthy SMS texting, In-person cognitive rehabilitation)
Recruiting
- Low-grade Glioma
- ReMind iPad app
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 16, 2022
3D Specimen Maps for RT Planning
Recruiting
- Head and Neck Cancer
- +2 more
-
Nashville, TennesseeVanderbilt Medical Center
Feb 23, 2023
Rectal Cancer Trial in Fuzhou (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- split-course hypofraction radiotherapy
- +3 more
-
Fuzhou, Fujian, ChinaPan Chi
Jul 23, 2023
Penile Cancer, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)
Recruiting
- Penile Cancer
- Margin Assessment
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 16, 2022
Squamous Cell Carcinoma of Head and Neck Trial in Aurora, Colorado Springs, Highlands Ranch (Atezolizumab, Stereotactic Body
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Atezolizumab
- Stereotactic Body Radiation Therapy
-
Aurora, Colorado
- +3 more
Jun 15, 2022
Prostate Cancer Trial in United States (drug, device, procedure)
Recruiting
- Prostate Cancer
- Administration of IS-002
- +2 more
-
San Francisco, California
- +3 more
Jul 7, 2023
HPV-positive Oropharyngeal Squamous Cell Carcinoma Trial in New York (procedure, radiation, drug)
Recruiting
- HPV-positive Oropharyngeal Squamous Cell Carcinoma
- Robotic surgery
- +2 more
-
New York, New YorkMount Sinai Health System
Oct 26, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC
Recruiting
- Prostate Adenocarcinoma
- +7 more
- High-Dose Rate Brachytherapy
- Stereotactic Body Radiation Therapy
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022
Breast Cancer Trial in Durham (Single fraction of 7 Gy)
Terminated
- Breast Cancer
- Single fraction of 7 Gy
-
Durham, North CarolinaDuke Cancer Center
Mar 29, 2022